NatureWise Biotech & Medicals Corporation (TPEX:4732)
19.00
-0.05 (-0.26%)
May 29, 2026, 1:11 PM CST
TPEX:4732 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 97.68 | 319.95 | 112.55 | 98.97 | 155.56 |
Short-Term Investments | 372.71 | 294.78 | 362.71 | 344.41 | 292.02 |
Trading Asset Securities | - | - | - | 50.6 | 50.29 |
Cash & Short-Term Investments | 470.39 | 614.73 | 475.26 | 493.98 | 497.87 |
Cash Growth | -23.48% | 29.35% | -3.79% | -0.78% | 5.45% |
Accounts Receivable | 60.67 | 56.73 | 55.17 | 64.35 | 65.48 |
Other Receivables | 2.42 | 1.61 | 1.93 | - | - |
Receivables | 63.08 | 58.35 | 57.1 | 64.35 | 65.48 |
Inventory | 79.46 | 84.37 | 82.5 | 59.56 | 55.8 |
Prepaid Expenses | - | - | - | 4.15 | - |
Other Current Assets | 24.76 | 13.22 | 12.15 | 0.23 | 4.63 |
Total Current Assets | 637.69 | 770.67 | 627.01 | 622.26 | 623.77 |
Property, Plant & Equipment | 12.48 | 3.96 | 8.62 | 3.63 | 8.26 |
Goodwill | - | 8.54 | 8.54 | 8.54 | 8.54 |
Other Intangible Assets | 26.39 | 22.85 | 28.84 | 33.97 | 38.93 |
Long-Term Deferred Tax Assets | 15.17 | 28.44 | 20.16 | 19.14 | 19.4 |
Other Long-Term Assets | 21.15 | 6.13 | 5.28 | 5.06 | 5.66 |
Total Assets | 712.87 | 840.59 | 698.45 | 692.6 | 704.57 |
Accounts Payable | 16.18 | 12.97 | 22.98 | 8.8 | 22.99 |
Accrued Expenses | - | 13.54 | 15.43 | 22.41 | 30.53 |
Current Portion of Leases | 4.78 | 3.35 | 4.52 | 2.7 | 3.94 |
Current Income Taxes Payable | - | 8.39 | 0.1 | 0.68 | 1.33 |
Current Unearned Revenue | 5.15 | 6.51 | 5.67 | 4.34 | 7.49 |
Other Current Liabilities | 33.72 | 5.68 | 5.59 | 3.92 | 2.09 |
Total Current Liabilities | 59.82 | 50.44 | 54.29 | 42.85 | 68.37 |
Long-Term Leases | 6.71 | 0.06 | 3.27 | - | 2.7 |
Long-Term Deferred Tax Liabilities | 1.56 | 2.54 | 3.33 | 4.24 | 5.15 |
Other Long-Term Liabilities | 4 | 4 | 4 | 4 | 4 |
Total Liabilities | 72.1 | 57.03 | 64.89 | 51.09 | 80.22 |
Common Stock | 493.96 | 492.9 | 492.9 | 492.9 | 492.9 |
Additional Paid-In Capital | 194.79 | 193.65 | 77.67 | 70.84 | 69.13 |
Retained Earnings | -36.96 | 55.33 | 64.29 | 78.81 | 63.57 |
Treasury Stock | -26.44 | - | - | - | - |
Comprehensive Income & Other | -1.01 | -0.86 | -1.29 | -1.04 | -1.26 |
Total Common Equity | 624.35 | 741.02 | 633.56 | 641.51 | 624.35 |
Minority Interest | 16.43 | 42.54 | - | - | - |
Shareholders' Equity | 640.78 | 783.56 | 633.56 | 641.51 | 624.35 |
Total Liabilities & Equity | 712.87 | 840.59 | 698.45 | 692.6 | 704.57 |
Total Debt | 11.49 | 3.4 | 7.78 | 2.7 | 6.64 |
Net Cash (Debt) | 458.9 | 611.33 | 467.48 | 491.28 | 491.23 |
Net Cash Growth | -24.93% | 30.77% | -4.84% | 0.01% | 4.65% |
Net Cash Per Share | 9.40 | 12.27 | 9.37 | 9.93 | 9.96 |
Filing Date Shares Outstanding | 48.39 | 49.29 | 49.2 | 49.29 | 49.29 |
Total Common Shares Outstanding | 48.39 | 49.29 | 49.2 | 49.29 | 49.29 |
Working Capital | 577.87 | 720.23 | 572.72 | 579.42 | 555.41 |
Book Value Per Share | 12.90 | 15.03 | 12.88 | 13.02 | 12.67 |
Tangible Book Value | 597.96 | 709.62 | 596.18 | 599 | 576.88 |
Tangible Book Value Per Share | 12.36 | 14.40 | 12.12 | 12.15 | 11.70 |
Machinery | - | 7.7 | 7.58 | 7.58 | 7.61 |
Leasehold Improvements | - | 5.19 | 5.19 | 4.88 | 5.08 |